Bulletin BiblioDem 2023-20-8/9

Abstract

1. Grasset L, Planche V, Bouteloup V, Azouani C, Dubois B, Blanc F, et al. Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort. Alzheimers Dement. 2023. 2. Hirabayashi N, Honda T, Hata J, Furuta Y, Shibata M, Ohara T, et al. Association Between Frequency of Social Contact and Brain Atrophy in Community-Dwelling Older People Without Dementia: The JPSC-AD Study. Neurology. 2023;101(11):e1108-e17. 3. Johansen MC, Ye W, Gross A, Gottesman RF, Han D, Whitney R, et al. Association Between Acute Myocardial Infarction and Cognition. JAMA Neurol. 2023;80(7):723-31. 4. Jonsson L, Wimo A, Handels R, Johansson G, Boada M, Engelborghs S, et al. The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint. Lancet Reg Health Eur. 2023;29:100657. 5. Nelson PT, Schneider JA, Jicha GA, Duong MT, Wolk DA. When Alzheimer's is LATE: Why Does it Matter? Ann Neurol. 2023;94(2):211-22. 6. Oostra DL, Nieuwboer MS, Melis RJF, Remers TEP, Olde Rikkert MGM, Perry M. DementiaNet facilitates a sustainable transition toward integrated primary dementia care: A long-term evaluation. Alzheimers Dement. 2023. 7. Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, et al. Trial of Solanezumab in Preclinical Alzheimer's Disease. N Engl J Med. 2023;389(12):1096-107. 8. Wiese LAK, Gibson A, Guest MA, Nelson AR, Weaver R, Gupta A, et al. Global rural health disparities in Alzheimer's disease and related dementias: State of the science. Alzheimers Dement. 2023;19(9):4204-25.